Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 16:05 | 3/2/26 | FENC | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | D | 6 | M.d | 358 | 4.61 | 0 | 78 | 245 | 109 | D | |||||||||||||||
3/3/26 16:05 | 3/2/26 | FENC | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | D | 6 | S.d | -358 | 4.61 | 0 | -78 | 109 | D | ||||||||||||||||
2/19/26 18:44 | 2/18/26 | FENC | Health | BioPrd | Biological Products, (No Diag | Hackman Jeffrey S. | NC | DO | CEO | 1 | M | 0 | 0.00 | 0 | 14 | 91 | 29 | D | ||||||||||||||
2/19/26 18:43 | 2/18/26 | FENC | Health | BioPrd | Biological Products, (No Diag | Andrade Robert | NC | O | CFO | 4 | M.d | 94 | 1.47 | 0 | 64 | 36 | 242 | D | ||||||||||||||
12/29/25 16:34 | 12/24/25 | FENC | Health | BioPrd | Biological Products, (No Diag | Southpoint Capital Advisors LP | NY | T | 1 | S | -7,500 | 7.50 | 0 | -1,000 | 2,745 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |